跳至主要内容
临床试验/NCT02762890
NCT02762890已完成不适用

Comparison of Deep Neuromuscular Block and Moderate Neuromuscular Block on Quality of Recovery in Patients Undergoing Robotic Gastrectomy

Yonsei University1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2016年10月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
1
主要终点
Postoperative quality of recovery

研究概览

简要总结

The purpose of this study is to investigate and compare the postoperative quality of recovery between the deep neuromuscular blockade and moderate neuromuscular blockade during robotic gastrectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients aged 19-80 years who are scheduled for robotic gastrectomy

排除标准

  • Neuromuscular disease
  • History of malignant hyperthermia
  • Significant renal or hepatic dysfunction
  • Allergy to sugammadex or rocuronium

研究组 & 干预措施

Deep neuromuscular blockade

Experimental

Rocuronium will be administered continuously to achieve post-tetanic count 1-2 during surgery.

干预措施: Deep neuromuscular blockade (Drug)

Moderate neuromuscular blockade

Active Comparator

Rocuronium will be administered continuously to achieve Train-of-four 1-2 during surgery.

干预措施: Moderate neuromuscular blockade (Drug)

结局指标

主要结局

Postoperative quality of recovery

时间窗: within 48 hours after the end of surgery.

The postoperative quality of recovery will be evaluated at 24 and 48 hours after the end of surgery by the investigator who are blinded to the group assignments.

次要结局

  • Surgical condition(within 48 hours after the end of surgery)
  • shoulder pain(within 48 hours after the end of surgery)
  • abdominal pain(within 48 hours after the end of surgery)
  • nausea and vomiting(within 48 hours after the end of surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验